CTOs on the Move

Apeel Sciences

www.Apeel.com

 
Apeel Sciences creates products from natural plant extracts that allow growers to reduce reliance on pesticides, increase produce quality, and provide superior shelf life without refrigeration.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million
  • www.Apeel.com
  • 819 Reddick Street
    Santa Barbara, CA USA 93103
  • Phone: 877.926.5184

Executives

Name Title Contact Details
Susan McCain
Vice President, Associate General Counsel, Intellectual Property and Risk Profile
Stephen Kaun
Senior Director, Technology Profile

Funding

Apeel Sciences raised $33M on 12/13/2016
Apeel Sciences raised $70M on 07/31/2018
Apeel Sciences raised $30M on 10/27/2020

Similar Companies

Aspect DV

Aspect DV is a Merrimack, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Core Information Technology

Core Information Technology is a Salem, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Economist Intelligence Unit

Economist Intelligence Unit is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

deCODE genetics

deCODE genetics is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Triplet Therapeutics

Triplet Therapeutics is a biotechnology company developing transformational treatments for patients with repeat expansion disorders (REDs) -- a group of more than 50 known genetic diseases including Huntington`s disease, myotonic dystrophy, spinocerebellar ataxias, fragile X syndrome, and familial amyotrophic lateral sclerosis (ALS) -- leveraging insights from patient genetics. Triplet designs and develops potential therapeutics for REDs using its proprietary thRED Engine, which enables the Company to develop a single oligonucleotide targeting the DNA Damage Response (DDR) pathway to potentially treat multiple REDs. Triplet is backed by investments from Atlas Venture, MPM Capital and Pfizer Ventures, along with Invus, Partners Innovation Fund and Alexandria Venture Investments.